Interaction of Left Ventricular Remodeling and Regional Dyssynchrony on Long-Term Prognosis after Cardiac

Bhupendar Tayal1, Peter Sogaard2, Antonia Delgado-Montero3

  • 1Division of Cardiology, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.

Insights

Severe left ventricular (LV) remodeling in heart failure (HF) patients receiving cardiac resynchronization therapy (CRT) is linked to worse outcomes. Less dilated ventricles showed better prognosis and resynchronization potential after CRT.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Medical Device Technology

Background:

  • Left ventricular (LV) remodeling, characterized by chamber dilation, is a known predictor of poor outcomes in heart failure (HF).
  • The influence of LV dilation on the effectiveness of cardiac resynchronization therapy (CRT) and its impact on prognosis remains incompletely understood.

Purpose of the Study:

  • To investigate the association between LV end-diastolic volume (EDVI) and long-term outcomes in CRT patients.
  • To assess the impact of LV dilation on the potential for resynchronization and its relationship with prognosis after CRT.

Main Methods:

  • Prospective study of 260 CRT patients (NYHA class II-IV, LVEF ≤ 35%, QRS ≥ 120 ms).
  • Quantitative echocardiography assessed LV volumes and mechanical dyssynchrony (radial strain) at baseline and 6-month follow-up.
  • Primary outcome: all-cause death or HF hospitalization over 4 years; Secondary outcome: all-cause death.

Main Results:

  • Patients with severely dilated LV (EDVI ≥ 90 mL/m²) had significantly worse prognosis for both primary (aHR, 2.20) and secondary (aHR, 1.94) events compared to those with less dilated LV.
  • Reduced baseline dyssynchrony was associated with better prognosis (primary: HR, 0.39; secondary: HR, 0.41), with a linear relationship between dyssynchrony reduction and event rates.
  • Patients with less dilated LV demonstrated significantly higher rates of dyssynchrony improvement post-CRT (OR, 4.10) compared to those with severe dilation.

Conclusions:

  • Severe LV remodeling (EDVI ≥ 90 mL/m²) predicts a poor prognosis in patients undergoing CRT.
  • Impaired resynchronization efficacy in severely dilated ventricles likely contributes to the worse outcomes observed after CRT implantation.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
695
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
602
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
807
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K